跳至主要内容
临床试验/jRCT1030240071
jRCT1030240071招募中不适用

JDEPTH-LM Registry: Japanese Coronary Intervention using Drug Eluting and Perfusion Therapy for Left Main Disease

N/A0 个研究点目标入组 280 人开始时间: 2024年5月27日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
280
主要终点
Procedure success rate

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18age old over 至 No limit(—)
性别
All

入选标准

  • Age >= 18 years
  • Patient with stable coronary artery disease, non-ST-elevation myocardial infarction, or unstable angina
  • Left main disease confirmed by coronary angiography or coronary CT angiography
  • Clinical and anatomical eligibility for PCI as agreed by the local Heart Team
  • Patient with consent prior to undergoing PCI
  • Left main Medina classification (1,1,1), (1,0,1), (0,1,1) and (0,0,1) confirmed by coronary angiography
  • De novo target lesion in LMT-LAD amenable for crossover stenting with provisional side-branch approach as determined by PCI operator
  • De novo ostial LCx lesions
  • Lesion indicated in No. 8 with a length of less than 10 mm or a stenosis of less than 70% confirmed by coronary angiography

排除标准

  • Inability to provide written informed consent
  • Patient with a history of ST-elevation myocardial infarction within the previous 1 week
  • Patient in a state of cardiogenic shock
  • Patient with a history of coronary artery bypass grafting
  • Patient with malignant tumors or other conditions with a life expectancy of less than one year
  • Patient considered suitable for stent placement in the ostial LCx from a medical perspective
  • Patient considered unsuitable for anti-thrombotic therapy after PCI
  • Other patient whom the investigator deems unsuitable for the safe conduct of LM-PCI, including W-KBT

结局指标

主要结局

Procedure success rate

indicating the proportion of cases meeting the following three conditions: - Device delivery success - Achievement of DCB expansion for 30 seconds or more - No bailout stenting performed in the LCx

MACE at 12 months

时间窗: 12 months

consisting of all-cause mortality, nonfatal MI, and ischemia-driven unplanned revascularization for left main disease

次要结局

  • Time to ST-change from DCB inflation
  • Total DCB Inflation time
  • Maximum changes in blood pressure and heart rate
  • Use of vasopressors, inotropes, and mechanical circulatory support systems after W-KBT(after W-KBT)
  • Incidence cases for each component of MACE and ischemia-driven unplanned revascularization for lesions at the LCx ostium

研究者

发起方
N/A

相似试验

JDEPTH-LM Registry | 临床试验